Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation

(2010) Carlos Fernández-de Larrea et al.   TRANSPLANTATION

Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation

(2009) Jean-Claude Davin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Safety and Long-Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic-Uremic Syndrome

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

Eculizumab for Atypical Hemolytic–Uremic Syndrome

(2009) Jens Nürnberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe atypical HUS caused by CFH S1191L—case presentation and review of treatment options

(2009) Sudarsana De et al.   PEDIATRIC NEPHROLOGY

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome

(2008) Gema Ariceta et al.   PEDIATRIC NEPHROLOGY